Paradigm Biopharmaceuticals (ASX:PAR) Pre-Tax Income : A$-69.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Paradigm Biopharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Paradigm Biopharmaceuticals's pretax income for the six months ended in Dec. 2023 was A$-48.96 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was A$-69.00 Mil. Paradigm Biopharmaceuticals's pretax margin was %.

During the past 8 years, Paradigm Biopharmaceuticals's highest Pretax Margin was -49683.54%. The lowest was -164288.10%. And the median was -110446.81%.

Paradigm Biopharmaceuticals Pre-Tax Income Historical Data

The historical data trend for Paradigm Biopharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paradigm Biopharmaceuticals Pre-Tax Income Chart

Paradigm Biopharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Pre-Tax Income

Get a 7-Day Free Trial

-15.63

-12.30

-34.30

-39.25

-51.91

Paradigm Biopharmaceuticals Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial												-26.99	-12.27	-31.87	-20.04	-48.96

Competitive Comparison of Paradigm Biopharmaceuticals's Pre-Tax Income

For the Biotechnology subindustry, Paradigm Biopharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Paradigm Biopharmaceuticals's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Paradigm Biopharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Paradigm Biopharmaceuticals's Pre-Tax Income falls into.

Paradigm Biopharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Paradigm Biopharmaceuticals's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-60.039	+	6.742	+	-0.016	+	1.403	+	7.105427357601E-15
	=	-51.91

Paradigm Biopharmaceuticals's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-50.298	+	1.061	+	-0.006	+	0.212	+	0.073
	=	-48.96

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-69.00 Mil.

Paradigm Biopharmaceuticals (ASX:PAR) Pre-Tax Income Explanation

Paradigm Biopharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-48.958	/	0
	=	%

During the past 8 years, Paradigm Biopharmaceuticals's highest Pretax Margin was -49683.54%. The lowest was -164288.10%. And the median was -110446.81%.

Paradigm Biopharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Paradigm Biopharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Paradigm Biopharmaceuticals (ASX:PAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Paradigm Biopharmaceuticals Ltd (ASX:PAR) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

PBIGF:USA

Address

500 Collins Street, Level 15, Melbourne, VIC, AUS, 3000

Website

https://www.paradigmbiopharma.com

Paradigm Biopharmaceuticals Ltd is a biopharmaceutical company that engages in the research and development of therapeutic products for human use in Australia. The firm is engaged in drug repurposing, pentosan polysulphate sodium (PPS) for the lead clinical indication of bone marrow edema, Alphavirus - Ross River virus (RRV) and Chikungunya virus (CHIKV), Mucopolysaccharidosis, and allergic respiratory conditions, including allergic rhinitis (AR) and chronic obstructive pulmonary disease (COPD).